A PHASE I TRIAL USING PATUPILONE (EPOTHILONE B) AND CONCURRENT

被引：0
|
作者：
Fogh, Shannon E.
Machtay, Mitchell
Werner-Wasik, Maria
Curran, Walter
Bonanni, Roseann
Axelrod, Rita
Andrews, David W.
Dicker, Adam P.
机构：
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：663 / 663
页数：1
相关论文
共 50 条
  • [41] Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
    B Melichar
    E Casado
    J Bridgewater
    J Bennouna
    M Campone
    P Vitek
    J-P Delord
    J Cerman
    R Salazar
    J Dvorak
    C Sguotti
    P Urban
    K Viraswami-Appanna
    E Tan
    J Tabernero
    British Journal of Cancer, 2011, 105 : 1646 - 1653
  • [42] Phase 1 trial of a novel epothilone, KOS-1584, using a weekly dosing schedule
    Burris, H.
    Stopeck, A.
    Thomas, E.
    Jones, S.
    Cohen, J.
    Dice, K.
    Dampier, B.
    Cropp, G. F.
    Zhong, Z.
    Hannah, A. L.
    EJC SUPPLEMENTS, 2006, 4 (12): : 192 - 192
  • [43] Complementary in vitro and in vivo study of the promising combined treatment modality of ionizing radiation and patupilone (EPO906, epothilone B)
    Hofstetter, B
    Oehler, C
    Vuong, V
    Broggini-Tenzer, A
    Ciernik, IF
    Wergin, M
    Wartmann, M
    Rüetz, S
    McSheehy, P
    Pruschy, M
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S49 - S50
  • [44] Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study
    McDaid, HM
    Mani, S
    Shen, HJ
    Muggia, F
    Sonnichsen, D
    Horwitz, SB
    CLINICAL CANCER RESEARCH, 2002, 8 (07) : 2035 - 2043
  • [45] Phase I dose-escalating trial of KOS-862 (epothilone D) in patients with advanced malignancies
    Rosen, L
    Kabbinavar, F
    Rosen, P
    Hecht, JR
    Parson, M
    Cropp, G
    McDaid, H
    Han, J
    Johnson, R
    Hannah, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S41 - S41
  • [46] Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes
    Denduluri, Neelima
    Low, Jennifer A.
    Lee, James J.
    Berman, Arlene W.
    Walshe, Janice M.
    Vatas, Ujala
    Chow, Catherine K.
    Steinberg, Seth M.
    Yang, Sherry X.
    Swain, Sandra M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) : 3421 - 3427
  • [47] A phase I trial of S-I with concurrent radiotherapy for locally advanced pancreatic cancer
    Ikeda, M.
    Okusaka, T.
    Ito, Y.
    Ueno, H.
    Morizane, C.
    Furuse, J.
    Ishii, H.
    Kawashima, M.
    Kagami, Y.
    Ikeda, H.
    BRITISH JOURNAL OF CANCER, 2007, 96 (11) : 1650 - 1655
  • [48] The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium
    Nimeiri, Halla S.
    Singh, Deepti A.
    Kasza, Kristen
    Taber, David A.
    Ansari, Rafat H.
    Vokes, Everett E.
    Kindler, Hedy L.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (06) : 854 - 858
  • [49] Phase II trial of patupilone in patients with brain metastases from breast cancer
    Peereboom, David M.
    Murphy, Conleth
    Ahluwalia, Manmeet S.
    Conlin, Alison
    Eichler, April
    Van Poznak, Catherine
    Baar, Joseph
    Elson, Paul
    Seidman, Andrew D.
    NEURO-ONCOLOGY, 2014, 16 (04) : 579 - 583
  • [50] Phase I/II dose-escalation trial of patupilone every 3 weeks in patients with resistant/refractory ovarian cancer
    Smit, W. M.
    Sufliarsky, J.
    Spanik, S.
    Wagnerova, M.
    Kaye, S.
    Oza, A. M.
    Gore, M.
    Williams, K. J.
    Johri, A.
    Huinink, W. W. ten Bokkel
    EJC SUPPLEMENTS, 2005, 3 (02): : 261 - 262
12345